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The prognosis for patients with malignant mesothelioma is very poor with patient 
response to therapy highly variable. This project was aimed at investigating the 
degree of heterogeneity in the responses to treatment amongst mesothelioma cell 
lines which have all arisen due to asbestos exposure. Despite the use of the same 
carcinogen, a number of variabilities amongst these cancers are still present. 
Avenues of investigation initially tried to determine if the variability in response was 
due to heterogeneity in the proliferation of malignant mesothelioma cells. Different 
growth rates were observed for cell lines grown in culture and in vivo. Cells showed 
different degrees of response to treatment with different chemotherapeutic agents. 
An attempt was made to determine the mode of cell death undergone by cells in their 
response to the treatments. Further investigation is warranted into the validity of 
these results because if the differences found in the phenotype of the cells were 
accurate, it could direct individualised therapeutic strategies to target the uniqueness 
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